Kaposi Sarcoma of the Ureter After Liver Transplant: Case Report and Literature Review

2012 ◽  
Vol 10 (1) ◽  
pp. 70-72
Author(s):  
Yu Chen ◽  
Liang Zhao ◽  
Shao-peng Qiu ◽  
Xiao-shun He
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Liver Transplant ◽  
Kaposi Sarcoma

scholarly journals Oral Kaposi Sarcoma in HIV-seronegative Saudi patient: Literature review and case report

2017 ◽  
Vol 29 (3) ◽  
pp. 129-134 ◽  
Author(s):  
Asmaa Faden ◽  
Manal AlSheddi ◽  
Mohammed AlKindi ◽  
Lama Alabdulaaly
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Kaposi Sarcoma

Asymptomatic Histoplasma Pylephlebitis in an Orthotopic Liver Transplant Recipient: A Case Report and Literature Review

2018 ◽  
Vol 184 (1) ◽  
pp. 177-180 ◽  
Author(s):  
Pakpoom Phoompoung ◽  
Methee Chayakulkeeree ◽  
Popchai Ngamskulrungroj ◽  
Ananya Pongpaibul
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Transplant Recipient ◽  
Liver Transplant ◽  
Liver Transplant Recipient ◽  
Orthotopic Liver Transplant

Antiviral Therapy of Symptomatic HCV-mixed Cryoglobulinemia after Liver Transplant: Case Report and Literature Review

2013 ◽  
Vol 36 (5) ◽  
pp. 367-372 ◽  
Author(s):  
Maria Francesca Donato ◽  
Giovanni Banfi ◽  
Donata Cresseri ◽  
G. Battista Fogazzi ◽  
Paul Martin ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Liver Transplant ◽  
Antiviral Therapy ◽  
Mixed Cryoglobulinemia

scholarly journals Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Ayaka Ishihara ◽  
Shuji Hatakeyama ◽  
Jun Suzuki ◽  
Yusuke Amano ◽  
Teppei Sasahara ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Cumulative Dose ◽  
Liposomal Doxorubicin ◽  
Cardiac Toxicity ◽  
Pegylated Liposomal Doxorubicin ◽  
Kaposi Sarcoma ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction

Abstract Background Pegylated liposomal doxorubicin plays an important role in the treatment of patients with severe refractory human immunodeficiency virus (HIV)-associated Kaposi sarcoma (KS). High cumulative doses of conventional doxorubicin exceeding 500 mg/m2 are known to cause cardiac toxicity. However, the safe cumulative dose of pegylated liposomal doxorubicin is unclear. Case presentation A 40-year-old Japanese man with HIV infection presented with pain, edema, and multiple skin nodules on both legs which worsened over several months. He was diagnosed with HIV-associated KS. He received long-term pegylated liposomal doxorubicin combined with antiretroviral therapy for advanced, progressive KS. The cumulative dose of pegylated liposomal doxorubicin reached 980 mg/m2. The patient’s left ventricular ejection fraction remained unchanged from baseline during treatment. After he died as a result of cachexia and wasting, caused by recurrent sepsis and advanced KS, an autopsy specimen of his heart revealed little or no evidence of histological cardiac damage. We also conducted a literature review focusing on histological changes of the myocardium in patients treated with a cumulative dose of pegylated liposomal doxorubicin exceeding 500 mg/m2. Conclusions This case report and literature review suggest that high (> 500 mg/m2) cumulative doses of pegylated liposomal doxorubicin may be used without significant histological/clinical cardiac toxicity in patients with HIV-associated KS.

scholarly journals Alagille syndrome and liver transplant as a therapeutic method – case report and literature review

HPB ◽  
2016 ◽  
Vol 18 ◽  
pp. e543
Author(s):  
J.O. Varaschin Zeni ◽  
A. Vinholi ◽  
H.N. Rasera ◽  
G.P. Ramos ◽  
L.M. Sarquis ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Liver Transplant ◽  
Alagille Syndrome ◽  
Therapeutic Method
Sign in / Sign up

Export Citation Format

Share Document